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Small regulatory RNAs supplement the canonical pathways of gene regulation
through diverse mechanisms of transcriptional, post-transcriptional, and post-translational
silencing. These mechanisms range from “classical” RNA interference (RNAi), to gene
repression by microRNAs (miRNAs), to maintenance of genomic stability by repeatassociated small RNAs. Here, I describe the contribution of miRNA-mediated regulation
to a specific case of gene expression that requires significant somatic alteration of the
genetic code.
B lymphocytes perform somatic hypermutation (SHM) and class switch
recombination (CSR) of the immunoglobulin locus to generate an antibody repertoire
diverse in both affinity and function. These somatic diversification processes are
catalyzed by activation-induced cytidine deaminase (AID), a potent DNA mutator whose
expression and function are highly regulated. I show that AID is regulated posttranscriptionally by a lymphocyte-specific microRNA, miR-155. I find that miR-155 is
upregulated in murine B lymphocytes undergoing CSR, and targets a conserved site in
the 3’untranslated region of the AID mRNA. Disruption of this target site in vivo results
in quantitative and temporal deregulation of AID expression, accompanied by functional
consequences for CSR and affinity maturation.

Thus, miR-155, which is known to play important roles in regulating the germinal
center reaction, does so in part by directly downmodulating AID expression. Using a
novel transgenic approach, I have characterized a single miRNA – target pair that has
functional implications in adaptive immunity and maintenance of genome integrity. The
regulation of AID by miR-155 serves as a striking example of two distinct regulatory
mechanisms – small RNA regulation and somatic gene diversification – converging to
generate a physiologically beneficial response.
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CHAPTER 1: Introduction

1.1 The origins of molecular biology
The roots of modern molecular biology sprang from a 19th century monastery
garden, as an Austrian monk orchestrated meticulous cross-breedings between pea plants,
and catalogued the transmission of heritable traits through each botanical generation.
Gregor Mendel’s macroscopic genetic experiments laid the fundamental basis for our
current understanding of genes and genetics (Mendel, 1866). Mendel’s original concept
of “hereditary particles” has evolved through a series of seminal discoveries – the first
isolation of DNA from living cells (Miescher, 1869), the recognition that DNA carries
heritable information (Avery et al., 1944; Hershey and Chase, 1952), the description of
the DNA double helix structure (Franklin and Gosling, 1953; Watson and Crick, 1953;
Wilkins et al., 1953).
The original model for transmission of genetic information, the Central Dogma of
biology (Fig. 1), was articulated in varying forms by both Francis Crick and James
Watson (Crick, 1958, 1970; Watson, 1965). A modern biologist would mostly likely
superimpose Crick’s concept of information transmission between DNA-RNA-protein
with an additional layer of multidirectional communication among the biomolecular trio
generated through gene function and regulation (Fig. 1).
Much of gene function can be attributed to protein, which is understandably more
chemically diverse (and by inference, more functionally diverse) than either of its nucleic
acid precursors. However, an astonishing breadth of RNA function has been revealed
over the last several decades. In accordance with the central dogma, RNA does indeed
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function as an intermediary between the DNA code and its final incarnation as protein.
The biochemistry and behavior of these messenger RNAs (mRNAs), however, inject
copious amounts of additional information into the cycle of gene expression. mRNAs
can undergo editing, alternative splicing, and other co-transcriptional modifications that
substantially effect the quality and quantity of the encoded protein.
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1.2 Noncoding RNAs
The information-bearing mRNAs are accompanied by a diverse collection of
noncoding RNAs (ncRNAs), many of which participate in essential housekeeping
functions. Well-characterized ribonucleoprotein complexes containing ncRNAs are key
components of the gene expression infrastructure – functioning from early steps of
mRNA maturation, all the way to terminal processes of protein export. The spliceosome
includes several small nuclear RNAs (snRNAs) that direct mRNA splicing (Black et al.,
1985; Bringmann et al., 1984; Chabot et al., 1985; Lerner et al., 1980; Rogers and Wall,
1980). Subsequent translation of these messages relies on decoding by ribosomal RNA
(rRNA) and transfer RNA (tRNA) in the context of the ribosome. Yet another class of
noncoding species, the small nucleolar RNAs (snoRNAs), guide site-specific chemical
modifications to rRNA, tRNA, and snRNA (Ganot et al., 1997; Ganot et al., 1999; Jady
and Kiss, 2001; Kiss-Laszlo et al., 1996; Ni et al., 1997; Omer et al., 2000; Tycowski et
al., 1998). The influence of ncRNAs also extends to protein export, as the noncoding
7SL RNA is an integral component of the signal recognition particle (SRP), which
regulates translocation of secretory and membrane proteins (Walter and Blobel, 1982).
Chromosomal architecture also depends on ncRNA function; telomerase maintains
chromosome ends by using an ncRNA component to template the reverse transcription of
telomeric repeats (Shippen-Lentz and Blackburn, 1990). Furthermore, ncRNAs can
actively function as independent catalytic units (Forster and Symons, 1987a, b; GuerrierTakada et al., 1983; Kruger et al., 1982; Kuo et al., 1988; Nielsen et al., 2005; SalehiAshtiani et al., 2006; Saville and Collins, 1990; Teixeira et al., 2004), and as direct
metabolic sensors in bacteria (riboswitches) (Epshtein et al., 2003; Mandal et al., 2003;
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Mandal et al., 2004; Sudarsan et al., 2003; Winkler et al., 2002a; Winkler et al., 2002b;
Winkler et al., 2003). Collectively, these regulatory ncRNAs form the structural and
enzymatic backbones of several biological processes.
It has become increasingly apparent, however, that ncRNA function may extend
far beyond housekeeping roles. Recent examinations of transcriptional landscapes have
revealed an astounding expanse of transcriptional activity throughout mammalian
genomes, far exceeding the number of protein-coding units (Birney et al., 2007; Okazaki
et al., 2002). These transcriptome maps depict an interlaced system of coding and
noncoding units yielding a considerable population of unannotated, uncharacterized long
ncRNAs. Though some of these noncoding transcripts may indeed represent non-specific
transcriptional noise (Struhl, 2007), recent studies indicate that both the process and
products of noncoding transcription are likely to be genuinely functional.
Bidirectional promoter activity contributes substantially to this pervasive
transcription. In yeast, the long noncoding products of this phenomenon have been
named Cryptic Unstable Transcripts (CUTs) and Stable Unannotated Transcripts (SUTs)
(Neil et al., 2009; Wyers et al., 2005; Xu et al., 2009). These ncRNAs emanate from
nucleosome-free promoters and 3’ termini of protein-coding units. Promoter-associated
CUTs and SUTs arise bidirectionally, giving rise to noncoding transcripts that can
overlap with neighboring mRNAs in either sense or antisense orientations. A few case
studies have shown that individual CUTs can mediate transcriptional silencing of
proximal genes (Berretta et al., 2008; Bird et al., 2006; Camblong et al., 2007; Hongay et
al., 2006). The ubiquity and genic association of these CUTs and SUTs in the yeast
transcriptome hint at a fundamental mechanism of regulating gene expression.
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Mammalian transcriptome profiles follow a strikingly similar pattern, with
clusters of ncRNAs arising at boundaries of transcribed genes. Long, unstable
PROMPTs (Promoter Upstream Transcripts) initiate bidirectionally ~0.5 to 2.5 kilobases
upstream of transcription start sites (Preker et al., 2008). The genomic addresses of
PROMPTs are enriched in markers of active transcription, such as RNA polymerase II
(Pol II) and acetylated histone H3 lysine 9, but do not associate with transcription
initiation factors that mark coding loci (Preker et al., 2008). PROMPTs partially overlap
with distinct class of bidirectional Promoter-Associated Long RNAs (PALRs) (Kapranov
et al., 2007). These PALRs initiate proximal to transcription start sites, with the resulting
ncRNA often overlapping the first exon and intron of the neighboring coding unit.
Several investigators have also independently identified short (<200 nucleotides)
noncoding transcripts (of varying size and stability) associated with the 5’ and 3’ termini
of genes: antisense Transcription Start Site Associated RNAs (TSSa-RNAs), antisense
Nuclear Run-on RNAs (NRO-RNAs), bidirectional Promoter Associated Short RNAs
(PASRs), and Termini Associated Short RNAs (TASRs) (Core et al., 2008; Kapranov et
al., 2007; Seila et al., 2008). The promoter-associated subset of these short ncRNAs
overlaps with PALRs (though not PROMPTs), suggesting that they may represent
processed versions of long ncRNAs associated with active transcription. These recent
discoveries depict a highly active transcriptional landscape, where induction of discrete
protein-coding genes is accompanied by a flurry of proximal noncoding transcription.
This system of pervasive genic and intergenic transcriptional activity, inherently
bidirectional promoters, and widespread polymerase pausing at promoters is not fully
understood; but has been proposed to alter DNA accessibility, create negative
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supercoiling to promote transcription initiation, or to poise pools of Pol II molecules for
rapid activation of associated genes.
Recent bioinformatic searches for conserved long ncRNAs indicate that they
comprise a small but substantial pool of bona fide functional species that are likely to
regulate many processes (Guttman et al., 2009). Only a few orphan examples of such
regulatory long ncRNAs have been characterized – but from these few case studies, a
startling diversity of regulatory modes have been uncovered.
Several of these regulatory long ncRNAs can be broadly categorized as
modulators of DNA accessibility, several instances of which have been documented in
yeast. Low abundance noncoding transcription through promoters of coding genes can
remodel the chromatin configuration to favor RNA polymerase access. This readthrough may arise in the same orientation as the coding gene (for example, the fission
yeast fbp1 locus) or in an antisense orientation (for example, the budding yeast pho5
locus) (Hirota et al., 2008; Uhler et al., 2007). The cascade of chromatin disruption
traveling towards the promoter appears to facilitate polymerase engagement of the coding
unit. A similar case of intergenic transcription is proposed to regulate chromatin opening
at the human β-globin locus (Gribnau et al., 2000).
In contrast, other ncRNAs associated with coding loci promote transcriptional
repression through a variety of mechanisms. This may take the form of transcriptional
interference in cis at promoter regions (Osato et al., 2007). One example of this takes
place at the SER3 gene in budding yeast. Noncoding transcription through the upstream
regulatory region of this gene (producing a ncRNA called Srg1) inhibits the binding of
transcriptional activators to the promoter, effectively repressing SER3 expression
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(Martens et al., 2004). A noncoding transcript initiating upstream of the human
dihydrofolate reductase (DHFR) promoter mediates transcriptional repression by a
different mechanism. This ncRNA forms a stable triplex with the promoter DNA, and
also interacts directly with the general transcription factor TFIIB to favor disassociation
of the preinitiation complex from the promoter (Martianov et al., 2007). This RNAdependent repression was also observed when the ncRNA was experimentally supplied in
trans, indicating that the RNA itself, and not simply transcription, was functionally
important.
Short ncRNA inhibitors of the core transcriptional machinery exist throughout
phylogeny: the bacterial 6S RNA, the murine B2 RNA, and human SINE-derived Alu
RNAs (Espinoza et al., 2004; Kettenberger et al., 2006; Mariner et al., 2008; Wassarman
and Storz, 2000). These RNAs bind directly to the polymerase, in some cases competing
with promoter DNA for access to the active site. In addition to ncRNA inhibitors of
transcriptional initiation, vertebrates also possess an RNA-based system to negate
transcriptional elongation. The elongation factor P-TEFb phosphorylates Pol II to
generate an elongating transcriptional complex. Elongation is obstructed, however, when
the noncoding transcript 7SK binds and represses the kinase activity of P-TEFb (Nguyen
et al., 2001; Yang et al., 2001).
Long ncRNAs also control gene expression through secondary interactions with
transcriptional co-factors. The murine developmental program illustrates one such
mechanism of transcriptional regulation in cis. The Dlx5/6 homeodomain gene cluster
(involved in limb patterning and neuronal development) gives rise to an intergenic
ncRNA, Evf-2, which binds another homeodomain protein (Dlx2) to cooperatively
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activate Dlx5/6 enhancer activity (Feng et al., 2006). ncRNA-mediated transcriptional
repression in cis has also been observed in the cellular response to DNA damage.
Genomic insults induce noncoding transcription upstream of the mammalian CCND1
locus, which encodes a cell cycle regulator that is repressed upon DNA damage. This
site-specific ncRNA tether recruits the RNA-binding protein TLS, which then inhibits
histone acetyltransferase activity at the downstream CCND1 gene (Wang et al., 2008).
Noncoding RNAs need not arise from the same genomic location as their regulated
targets. For example, the vertebrate heat shock response exhibits one mode of RNAinduced transcriptional activation. A long ncRNA called HSR1 induces the trimerization
of the heat shock transcription factor HSF1, activating its capacity to stimulate expression
of downstream targets (Shamovsky et al., 2006). Trans-acting ncRNAs can also function
as potent transcriptional repressors. The human Hox genes, which are responsible for
developmental body patterning, cluster in several discrete genomic loci. A recently
discovered intergenic ncRNA, HOTAIR, originates from the HoxC cluster, but targets a
distal HoxD gene cluster for Polycomb-mediated epigenetic silencing (Rinn et al., 2007).
These examples of protein-associated regulatory ncRNAs hint at a vast capacity for
cooperation between RNA- and protein-based mechanisms of gene regulation.
The influence of ncRNA also extends beyond transcriptional processes per se.
The subcellular trafficking of the transcription factor NFAT (nuclear factor of activated T
cells) serves as a prime example. Though the molecular details are not clear, the
noncoding NRON RNA interacts with nuclear importins, and somehow obstructs the
ability of NFAT to access its transcriptional targets (Willingham et al., 2005).
Furthermore, the prevalence of sense and antisense transcript pairs suggests that duplexed
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RNAs may be a common occurrence in mammalian transcriptomes (Katayama et al.,
2005; Okazaki et al., 2002). One functional example of overlapping noncoding
transcription has been described for the human Zeb2 mRNA. An antisense ncRNA
intersects with the splice site of its sense mRNA partner, preventing RNA splicing and
translation of a functional ZEB2 protein (Beltran et al., 2008).
Some of the best-characterized ncRNAs have been implicated in epigenetic
programming and imprinting. Long noncoding RNAs nucleate two distinct mechanisms
of dosage compensation (adjustment of the male XY versus female XX chromosome
inequity). X chromosome inactivation in female cells of placental mammals stems from
the mutually exclusive expression of two ncRNAs: Xist (expressed from the inactive X
chromosome), and its antisense counterpart Tsix (expressed from the active X
chromosome). Xist coating of the inactive X chromosome promotes heterochromatic
silencing through repressive histone modifications and DNA methylation (Borsani et al.,
1991; Brown et al., 1991; Panning et al., 1997; Panning and Jaenisch, 1996). In contrast,
dosage compensation in Drosophila takes the opposite route, where the single male X
chromosome undergoes hypertranscription, mediated by a ribonucleoprotein complex
containing the ncRNAs roX1 and roX2 (Ilik and Akhtar, 2009). A handful of imprinted
gene clusters are also associated with ncRNAs: H19 (Bartolomei et al., 1991), Nespas
(Wroe et al., 2000), Air (Sleutels et al., 2002), Kcnq1ot1 (Pandey et al., 2008) – which
are believed to participate in the epigenetic silencing of their respective loci.
Long ncRNAs represent an expansive class of regulatory molecules that touch on
multiple aspects of gene expression. Here, I have discussed only a few functional
examples that speckle the regulatory landscape. Given the ubiquity of these RNAs in the
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transcriptome, there are undoubtedly many more examples and mechanisms of ncRNA
function to be uncovered. It remains to be seen how (and if) these few characterized
ncRNAs relate to the extensive populations of yeast CUTs/SUTs or the mammalian
PROMPTs and PALRs, and if there are indeed broad classes of ncRNAs that act as
fundamental genomic regulators.

1.3 Small noncoding RNAs and gene silencing
In any discussion of ncRNAs, one must inevitably mention small ncRNAs,
several classes of which have been implicated in transcriptional and post-transcriptional
gene silencing (Fig. 2). The earliest signs of these silencing mechanisms were observed
in petunia plants carrying additional transgenic copies of a pigment biosynthesis gene
(Napoli et al., 1990). In an unexpected turn of events, these plants produced flowers with
variegated pigmentation or even complete lack of color, instead of more vividly-colored
flowers. This rather anomalous observation, called “co-suppression,” was later
recognized as the first phenotypic evidence of a gene silencing mechanism that was also
observed by others in fungi (Romano and Macino, 1992) and nematodes (Guo and
Kemphues, 1995).
The basis of this phenomenon, termed RNA interference (RNAi), was explained
in the landmark studies of Fire and Mello, who uncovered a double-stranded RNAtriggered gene silencing mechanism in C. elegans (Fire et al., 1998). The molecular
instigators of this silencing were found to be 21-25 nucleotide RNAs complementary to
genes undergoing RNAi (Hamilton and Baulcombe, 1999). These small interfering
RNAs (siRNAs) are processed from exogenous double-stranded RNAs by the RNaseIII-
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type enzyme Dicer (Bernstein et al., 2001; Hammond et al., 2000; Hutvagner et al., 2001;
Zamore et al., 2000). Mature siRNAs then integrate into the RNA-induced silencing
complex (RISC), and guide the RNA cleavage activity of its Argonaute subunit to a
complementary mRNA target (Hammond et al., 2001; Liu et al., 2004). These pathways
of siRNA biogenesis and silencing have been indentified in fungi, plants, protozoans, and
animals, representing a well-conserved mechanism of post-transcriptional gene
regulation.
In parallel, a related class of genomically-encoded small RNAs was discovered in
C. elegans (Lee et al., 1993; Wightman et al., 1993). These microRNAs (miRNAs) in
their mature form are biochemically indistinguishable from siRNAs, and also engage
many of the same effector agents as siRNAs. In contrast to siRNAs, however, miRNAs
arise from the multi-step processing of endogenous primary miRNA (pri-miRNA)
transcripts that contain one or more hairpin structures each encompassing a mature
miRNA sequence (Bartel, 2004). Distinct ribonucleases in the nucleus (Drosha) and
cytoplasm (Dicer) trim the hairpin structures into small RNA duplexes (Lee et al., 2003),
followed by incorporation of one strand of the duplex into an Argonaute-containing
silencing complex (Hutvagner and Zamore, 2002).
Plant miRNAs function predominantly as siRNAs, binding with full
complementarity to their cognate mRNAs and targeting them for endonucleolytic
cleavage (Llave et al., 2002; Rhoades et al., 2002). Animal miRNAs, in contrast, are
believed to recognize mRNA target sequences with partial complementarity, and mediate
silencing through translational repression (Bartel, 2004), as well as mRNA destabilization
(Mansfield et al., 2004; Yekta et al., 2004). The functional variation between plants and
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animals is thought to reflect two independent evolutionary origins for miRNAs (Axtell
and Bowman, 2008).
Though the current miRNA registry is by no means comprehensive, miRNAs
have been identified in most eukaryotic model organisms, with the exception of S.
cerevisiae (Griffiths-Jones et al., 2008). In humans, the known miRNAs number in the
several hundreds, some with evolutionary conservation reaching back to nematodes and
arthropods (Griffiths-Jones et al., 2008). An estimated 30% of eukaryotic genes are
subject to miRNA regulation (Lewis et al., 2003; Yu et al., 2007), implicating this
mechanism as a substantial means by which organisms modulate their gene expression
profiles.
Small RNA function also extends to chromatin-dependent and transcriptional
gene silencing. These modes of gene repression have been observed in plants, which
employ siRNAs and miRNAs to direct RNA-dependent DNA methylation and repressive
histone modifications (Bao et al., 2004; Gendrel et al., 2002; Henderson et al., 2006;
Zilberman et al., 2003). Kin of siRNAs and miRNAs also maintain heterochromatic
silencing of repetitive elements in the genomes of unicellular eukaryotes. Bidirectional
transcription of centromeric repeats in fission yeast gives rise to heterochromatic small
RNAs that recruit an Argonaute-containing protein complex called RITS (RNA-induced
initiation of transcriptional gene silencing) (Reinhart and Bartel, 2002). RITS-directed
histone tail methylation then maintains the silent state of centromere (Verdel et al., 2004;
Volpe et al., 2003; Volpe et al., 2002).
The most recently described small RNA subclass stands apart from siRNAs and
miRNAs in their size, biogenesis, and expression patterns. These are the Piwi-interacting
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small RNAs (piRNAs), 25-31 nucleotide species exclusively expressed in metazoan germ
cells (Hartig et al., 2007; O'Donnell and Boeke, 2007). Unlike their more diminutive
small RNA cousins, piRNAs arise in a Dicer-independent fashion, likely from a single
stranded RNA precursor transcribed from a piRNA gene cluster (Houwing et al., 2007;
Vagin et al., 2006). They partner with the Piwi subfamily of Argonaute proteins to
silence transposons in the male germline via DNA methylation – their only characterized
function to date (Aravin et al., 2008). In addition to silencing parasitic genome elements,
piRNAs likely play additional roles in mice, whose piRNA repertoire includes a
substantial subclass not complementary to repetitive transposon sequences (Aravin et al.,
2007).
The burgeoning literature on small RNA function reflects on the diversity of tasks
they perform in nearly all clades of life. They provide protection against endogenous
selfish genetic elements as well as exogenous sources of double-stranded RNA. With
direct relevance to the formal concept of immunity – plants generate siRNAs from
invading viral genomes as one component of their antiviral immune defenses (Ding and
Voinnet, 2007). The necessity of this mechanism, however, has dwindled in evolution
with the advent of more complex immune systems. Furthermore, small RNAs modulate
the flow of information from DNA to protein through transcriptional and posttranscriptional silencing mechanisms. Their influence is apparent throughout
development and physiological function.
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1.4 Somatic gene alteration in adaptive immunity
Rather than a simple on-off switch, gene expression involves a complex network
of transcriptional, post-transcriptional, and post-translational regulation. Thus, enormous
functional flexibility can be generated from a finite set of coding genes (estimated to
number around 30,000 (Venter et al., 2001)). However, the immune system provides a
striking example where the de facto information content of the genome is not sufficient
for full biological function. Vertebrates encounter innumerable pathogenic and
environmental insults throughout their lifetimes, and thus require a recognition system
capable of identifying these infinitely diverse particles as non-self. This demand for
diversity in recognition certainly exceeds the amount of information that can be encoded
in the entire genome, much less in one specific locus.
The innate immune system induces an immediate and non-specific inflammatory
response based on recognition of conserved pathogenic motifs such as bacterial
lipoproteins and viral double stranded DNA. Specialized cells such as macrophages and
dendritic cells recognize these invariant motifs via Toll-like receptors (TLRs), triggering
cytokine and chemokine production and recruitment of additional effector cells. The
innate response then gives way to the adaptive response, which hinges on the generation
of cellular receptors adapted to recognize specific epitopes. These specialized
recognition capacities can then be propagated for immunological memory. B
lymphocytes manufacture one of these key receptors – the immunoglobulins (Ig), also
known as antibodies.
The requisite diversity of the Ig repertoire is generated in stages, the first of which
occurs in an antigen-independent manner to create a pre-existing pool of B lymphocytes,
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each bearing a distinct Ig. In accordance with Burnet’s clonal selection theory (Burnet,
1957; Talmage, 1957), antigen-dependent selection then promotes the expansion and
maintenance of one particular Ig-bearing lymphocyte.
Over the last half century, the molecular basis of Ig repertoire diversification has
proven to stem from several elaborate gene rearrangements during B lymphocyte
development. The modular architecture of the Ig molecule reveals several opportunities
for generating both recognition and functional diversity. Two heavy chain and two light
chain polypeptides complex into a characteristic Y-shaped configuration. The N-terminal
prongs of the Y (Variable, or V region) specify the antigen-recognizing capacity, whereas
the C-terminal stem (Constant, or C region) specifies the effector functions of the
molecule (Fig. 3). To achieve the required functional diversity at both the V and C
regions, the Ig gene locus, occupying some several megabases, undergoes impressive
molecular acrobatics to facilitate somatic gene alterations during B lymphocyte
development.
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As hematopoietic stem cells commit to the B lineage in the bone marrow, they
activate transcriptional regulators (E2A, EBF, Pax5) that control the expression of genes
involved in Ig locus rearrangement (Matthias and Rolink, 2005). Committed pro-B
lymphocytes perform the first step of Ig gene diversification when they assemble their Ig
heavy chain V region genes. This process, called V(D)J recombination, involves the
sequential joining of three gene modules – Variable (V), Diversity (D), and Joining (J) –
to reconstitute a functional V region segment (Fig. 4) (Early et al., 1980; Early et al.,
1979; Maki et al., 1980; Sakano et al., 1981). Developing T lymphocytes in the thymus
also undergo an analogous process of V(D)J recombination at the T-cell receptor locus to
diversify the Variable regions of their cell-surface receptors (Chien et al., 1984; Kavaler
et al., 1984). Requiring three-dimensional folding of the DNA, the appropriate V, D, or J
segments are aligned according to flanking palindromic motifs called recombination
signal sequences (RSS) (Akira et al., 1987; Sakano et al., 1981; Tonegawa, 1983). The
DNA is then recognized and cleaved by the molecular engines of the V(D)J recombinase
– the Rag1 and Rag2 proteins (McBlane et al., 1995; Schatz and Baltimore, 1988; Schatz
et al., 1989; van Gent et al., 1995). Non-homologous end-joining (NHEJ) machinery
subsequently ligates the appropriate DNA ends (Gao et al., 1998; Grawunder et al., 1998;
Li et al., 1995; Moshous et al., 2001; Taccioli et al., 1993).
Productive (i.e. in-frame) V(D)JH recombination allows for the expression of an Ig
heavy chain, which associates with a surrogate light chain to form the pre-B-cell receptor
(pre-BCR) (Nishimoto et al., 1991). As pre-B lymphocytes, these progenitor cells
perform a second round of recombination at the Ig light chain locus, giving rise to fully
complexed Ig protein (Reth et al., 1987). Productive rearrangements result in

18

19

downregulation of the V(D)J recombination machinery to ensure allelic exclusion
(Grawunder et al., 1995). Signaling mediated by surface-expressed Ig on immature B
lymphocytes will then direct cell maturation, eventually leading to the emergence of
mature B lymphocytes from the bone marrow.
A mature B lymphocyte that has undergone V(D)J recombination is then distinct
from all others at three levels: 1) the random choice of V, D, and J from an extensive
pool of germline gene segments, 2) the combination of rearranged heavy and light chains,
and 3) junctional insertions and deletions which occur during rearrangement. Together,
this combinatorial and junctional diversity can produce a repertoire of distinct Ig variable
region specificities in excess of 107.
Chickens and rabbits employ a slightly different means to diversify Ig specificity
prior to antigen stimulation. V(D)J recombination in these animals has limited
diversification potential, as the Ig heavy and light chain loci harbor few functional V
region segments. Furthermore, most of the rearranged V regions preferentially choose
the same VH gene segment (Knight and Becker, 1990). Instead, a substantial number of
nonfunctional V- and J-like pseudogenes are exploited to generate variation through gene
conversion. Nucleotides from these pseudogenes are used as templates for sequence
conversions in the functional, rearranged V region gene (Becker and Knight, 1990;
Carlson et al., 1990; Reynaud et al., 1985; Reynaud et al., 1987; Reynaud et al., 1989;
Thompson and Neiman, 1987). Though V region pseudogenes exist in mouse and human
genomes, GC does not appear to contribute significantly to primary Ig diversification in
mammals.
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Upon expression of a functional Ig surface receptor, B lymphocytes exit the bone
marrow and circulate through the bloodstream to the peripheral lymphoid organs, such as
the spleen, lymph nodes, and Peyer’s Patches of the gut. These organs collect antigens
from the mucosal tracts, extracellular fluids, and blood, and present them for sampling by
the cells of the adaptive immune system. The germinal centers of these organs provide
the microenvironments where mature B lymphocytes undergo antigen-dependent
secondary diversification. The affinity of the newly assembled V region for its cognate
antigen is optimized through somatic hypermutation (SHM) of the V region gene (Fig. 4).
B lymphocytes expressing mutated Igs with high affinity for an antigen preferentially
receive the strongest survival signals, and are thus selected for propagation into clonal
populations of Ig-secreting plasma cells and memory B cells. This SHM-dependent
process is referred to as affinity maturation. Secondary diversification also influences the
effector function associated with a particular Ig. All B lymphocytes initially express the
IgM isotype, encoded by the Cµ constant region exons. Class switch recombination
(CSR) allows for any assembled V region to be expressed in conjunction with alternative
C exons to produce other Ig isotypes (IgG, IgE, IgA) with different effector functions.
This switching is achieved through deletional recombination at the C region locus (Fig.
4). The two processes of SHM and CSR cooperate to produce functionally optimized Igs
with high affinity towards their cognate antigens, and with effector function appropriate
for the stimulating antigen.
The three mechanistically dissimilar processes of GC, SHM, and CSR share a
common molecular trigger – conversion of cytidine to uracil by activation induced
cytidine deaminase (AID) (Fig. 5) (Arakawa et al., 2002; Muramatsu et al., 2000;
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Muramatsu et al., 1999). This enzyme was first identified by Honjo and colleagues, who
designated it as a novel member of the APOBEC family of polynucleotide cytidine
deaminases (Muramatsu et al., 1999). Noting the sequence homology between AID and
its well-characterized relative, APOBEC1 (an RNA deaminase), it was initially proposed
that AID edited and activated the mRNA of an SHM- or CSR-catalyzing factor. Though
we cannot formally exclude the possibility of AID-mediated RNA editing, the majority of
experimental observations are consistent with a model of DNA deamination induced by
AID. From this DNA-centric perspective of AID function, Ig diversification can be
understood as the differential processing of AID-dependent lesions in DNA by noncanonical repair pathways to generate either sequence conversions (GC), point mutations
(SHM), or DNA recombination (CSR).
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1.5 Somatic hypermutation, a closer look
Joshua Lederberg first proposed that that “genic diversity of the precursors of
antibody-forming cells arises from a high rate of spontaneous mutation” in 1959,
predating the breakthrough finding of AID by several decades (Lederberg, 1959).
Observed mutations at the V region, however, arise at a rate of 10-3 / base pair /
generation, several orders of magnitude above the rate of spontaneous mutation
(Lederberg, 1959). After the discovery of AID, it became clear that AID-mediated
deamination was responsible for the active mutation and affinity maturation of V regions.
Point mutations introduced into the V region are spatially limited to a 1-2 kilobase
range beginning about 150 base pairs downstream of the Ig V promoter. Mutation
frequency also decreases with increasing distance from the promoter (Rada and Milstein,
2001). The footprint of mutation coincides strikingly with the footprint of transcription,
and indeed, SHM has been shown to be intimately linked to transcription (Bachl et al.,
2001; Fukita et al., 1998). Active transcription bubbles are believed to generate the
preferred single-stranded DNA substrates for AID deamination. Storb and colleagues
posit that a mutator factor (presumably AID) associates with an RNA polymerase II
transcriptional complex, and deposits mutations as it tracks along the transcribed gene
(Longerich et al., 2005; Peters and Storb, 1996). The promoter-distal boundary of
mutation could then be defined by stochastic dissociation of the mutator from the
transcriptional complex. While the concurrence of hypermutation and robust
transcription is undeniable, the latter is not sufficient. With a few exceptions (Liu et al.,
2008; Odegard and Schatz, 2006; Pasqualucci et al., 2001), non-Ig genes are not
hypermutated even when highly transcribed. An Ig-specific targeting mechanism must
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exist, but the means of this targeting (Ig-targeted protein co-factors, Ig gene cis-elements,
differential chromatin accessibility) remains unknown.
SHM affects all four bases in DNA, with transition mutations predominant over
transversions (Golding et al., 1987). Primary sequence can bias the placement of
mutations, but in a very limited fashion. Mutated Cs often associate with canonical AID
hotspot motifs: WRCY (where W = A/T, R = A/G, and Y = C/T), or its complement
RGYW (Rogozin and Kolchanov, 1992). However, these so-called hotspots are not
absolute determinants of mutability, since not all mutated Cs lie in hotspots. Strand
placement can also affect mutability – while C:G base pairs mutate at equal frequencies
regardless of strand placement (template versus non-template), A:T base pairs mutate
preferentially when the A is placed in the template strand (34). This A:T strand polarity
is not understood, but may stem from asymmetric function of subsequent repair enzymes.
AID-mediated conversion of C to U is in itself mutagenic, as simple replication
over the site (with recognition of U as T) yields transition mutations. Secondary
processing of the initiating U:G DNA lesion, however, must occur to generate the full
spectrum of mutations. The current paradigm for SHM holds that error-prone versions of
base excision repair (BER) and mismatch repair (MMR) broadens the range of mutations
at C:G base pairs and A:T base pairs, respectively (Fig. 6).
Uracils occasionally appear in DNA due to stochastic deamination of cytidine or
misincorporation during replication (Krokan et al., 2002). Base excision repair (BER)
removes the unwelcome base using a uracil DNA glycosylase such as UNG, and allows
for faithful repair of the lesion. Hypermutating B cells, however, skew the BER pathway
to facilitate mutation at C:G base pairs. UNG-mediated cleavage of the uracil base from
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the DNA backbone creates an abasic site (Di Noia and Neuberger, 2002; Imai et al.,
2003; Rada et al., 2002). Translesion polymerases then replicate over this non-instructive
site to generate both transition and transversion mutations (Delbos et al., 2007; Delbos et
al., 2005; Jansen et al., 2006; Masuda et al., 2005; Zeng et al., 2004). There is also
evidence for a complementary pathway of abasic site processing mediated by the
Mre11/Rad50/Nbs1 (MRN) complex (Larson et al., 2005; Yabuki et al., 2005).
AID-mediated cytidine deamination also creates a U:G mismatch that can engage
the MMR machinery (Wilson et al., 2005). Mismatch recognition by the MSH2/MS6
heterodimer is followed by exonucleolytic gap formation and error-prone synthesis to
generate mutations distal to the initial uracil lesion. Genetic studies in mice tend to
support this idea of subverted MMR as a major source of mutations at A:T pairs
(Bardwell et al., 2004; Delbos et al., 2007; Delbos et al., 2005; Martomo et al., 2004;
Martomo et al., 2005; Phung et al., 1998; Rada et al., 1998; Wiesendanger et al., 2000;
Winter et al., 1998; Zan et al., 2001; Zan et al., 2005).
Cooperatively, error-prone BER and MMR generate a diverse spectrum of
mutation at the V region gene. How these two repair pathways (usually high fidelity)
detour into the realm of mutagenesis is not well understood. A recent study proposes that
the switch between error-free and error-prone synthesis depends on AID activity, where
Rad6/Rad18-mediated recognition of AID-induced DNA lesions triggers the
monoubiquitination of proliferating cell nuclear antigen (PCNA), which then
preferentially recruits error-prone polymerases (Bachl et al., 2006).
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1.6 Class switch recombination, a closer look
In the Ig heavy chain locus, several C region modules lie downstream of the V
region. With the exception of Cδ, each set of C region exons is preceded by a repetitive
G/C-rich DNA element, the switch (S) region. Nonhomologous recombination between
two S regions provides the basis of CSR. The mechanism of CSR exhibits some
superficial similarities to SHM, namely, transcription dependence, AID dependence, and
engagement of BER and MMR machinery.
At the constant regions, transcription is required in a noncoding capacity. These
transcripts initiate from cytokine-inducible, isotype-specific promoters located a few
kilobases upstream of each S region (Berton et al., 1989; Esser and Radbruch, 1989;
Gerondakis, 1990; Lebman et al., 1990; Lutzker et al., 1988; Rothman et al., 1990b;
Stavnezer-Nordgren and Sirlin, 1986; Xu and Stavnezer, 1990) (Fig. 7). These “germline
transcripts” do not code for protein, yet appear to play a necessary, but unknown role in
promoting CSR (Wakatsuki and Strober, 1993; Xu et al., 1993; Zhang et al., 1993). Two
additional observations further suggest that RNA-dependent mechanisms may regulate
the accessibility or targeting of the C regions: 1) splicing of the germline transcripts may
be necessary for the subsequent DNA recombination (Hein et al., 1998; Lorenz et al.,
1995), and 2) antisense transcription accompanies the sense germline transcription
(Chowdhury et al., 2008; Perlot et al., 2008). The full significance of these observations
is not yet clear.
Transcription may be key to generating the preferred single stranded DNA
substrate for AID. DNA-RNA hybrids, or R-loops, can form upon transcription of G/Crich elements such as S regions, thus exposing an unpaired DNA strand for AID
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deamination (Daniels and Lieber, 1995; Mizuta et al., 2003; Yu et al., 2003). Though
AID-dependent point mutations are detected in S regions after CSR (Schrader et al.,
2003), mutagenesis is far from the endpoint of CSR. Following AID catalysis at S
regions, CSR proceeds through three stages: generation of double-stranded DNA breaks
(DSBs), sensing and synapsis of said DNA breaks, and DNA end-joining (Fig. 7).
As in the V regions, AID-induced uracils in both strands of S region DNA are
recognized and removed by BER to create abasic sites (Rada et al., 2002; Schrader et al.,
2005). These sites can then be processed by apurinic/apyrimidinic endonucleases (APE)
to form single-stranded nicks (Guikema et al., 2007). Two nicks on opposite DNA
strands, if in close proximity, can destabilize the DNA duplex such that staggered doublestranded breaks form. MMR catalyzes an alternative, but minor pathway of DSB
formation (Bardwell et al., 2004; Ehrenstein and Neuberger, 1999; Ehrenstein et al.,
2001; Li et al., 2004; Martin et al., 2003; Martomo et al., 2004; Schrader et al., 1999;
Schrader et al., 2007; Stavnezer and Schrader, 2006). In preparation for end-joining, the
staggered DNA ends are believed to undergo blunting by either exonucleolytic resection
of overhangs or short-patch DNA synthesis by error prone polymerases.
The broken DNA ends attract canonical DNA-damage sensors such as
phosphorylated histone H2AX (γH2AX) (Petersen et al., 2001; Reina-San-Martin et al.,
2003), p53 binding protein 1 (53BP1) (Manis et al., 2004; Ward et al., 2004), ataxia
telangiectasia mutated protein (ATM) (Lumsden et al., 2004; Reina-San-Martin et al.,
2004), and the MRN complex (Difilippantonio et al., 2005; Reina-San-Martin et al.,
2005). The γH2AX-initiated accumulation of these factors effectively
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forms a protein scaffold to synapse broken ends from two different S regions that can lie
up to a hundred kilobases apart.
The final phase of CSR involves ligation of the synapsed DNA ends. Given the
limited homology between different S regions, it is unsurprising that components of the
nonhomologous end joining (NHEJ) pathway are important for CSR. Known NHEJ
factors such as the DNA end-binding complex Ku70/Ku80 (Casellas et al., 1998; Manis
et al., 1998), DNA-PKcs (Manis et al., 2002), XRCC4 (Soulas-Sprauel et al., 2007; Yan
et al., 2007) and DNA LigIV (Yan et al., 2007) facilitate efficient CSR. Mice deficient in
NHEJ, however, retain some CSR capacity, suggesting the existence of an alternative end
joining pathway (Han and Yu, 2008; Yan et al., 2007). Thus in the context of the Ig
constant region, the composite efforts of DNA deamination, BER, MMR, and end joining
can link any Ig antigen specificity (defined by the V region) to one of several Ig effector
functions (defined by the C region).

1.7 Regulation of AID
In the ten years since the first identification of AID, our understanding of the
molecular mechanisms behind Ig gene diversification has expanded immensely.
Biochemical modification of DNA in B lymphocytes, coupled with slightly off-kilter
DNA repair mechanisms, yield a diverse cell population that can induce potent cellular
and molecular defenses based on the recognition of very specific antigenic epitopes. The
implications for health are undeniable, as a number of human immunodeficiencies can be
traced to genetic defects in SHM or CSR components. For example, mutations in the
human AICDA or UNG genes lead to hyper-IgM syndrome, characterized by lack of CSR
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(and sometimes SHM), excessive accumulation of IgM in the serum, and heightened
susceptibility to infection (Kavli et al., 2005; Revy et al., 2000).
Though AID-mediated lymphocyte maturation produces great immunological
benefits, there are potential hazards to promiscuous AID activity. Ig gene diversification
proceeds through highly genotoxic molecular intermediates: mutations and single
stranded DNA breaks in SHM, and double stranded DNA breaks in CSR. Indeed, AID
does induce oncogenic translocations between the IgH locus and the proto-oncogene cmyc (Ramiro et al., 2004; Robbiani et al., 2008). Given such deleterious repercussions on
genomic integrity, multiple mechanisms are in place to limit AID expression and activity.
With a few exceptions (Endo et al., 2008; Komori et al., 2008; Matsumoto et al.,
2007; Pauklin et al., 2009), AID is preferentially expressed in B lymphocytes. A network
of essential B lymphocyte transcription factors and cytokine-responsive transcription
factors demarcate the cell-specificity of AID expression (Dedeoglu et al., 2004; Gonda et
al., 2003; Park et al., 2009; Sayegh et al., 2003). A relatively lethargic rate of AID
catalysis places an intrinsic limit on activity. In vitro kinetic experiments demonstrate
that an AID molecule binds to a synthetic single-stranded bubble substrate with
nanomolar affinity, with the enzymatic consequence of only one deamination every four
minutes (Larijani et al., 2007). Such a long-lived AID-substrate complex would be
consistent with inferences of AID processivity (Larijani et al., 2007; Pham et al., 2003;
Shen and Storb, 2004) and observations of AID haploinsufficiency (Sernandez et al.,
2008; Takizawa et al., 2008).
These fundamental limits on AID expression and activity are supplemented by
post-translational regulatory mechanisms. A C-terminal nuclear export signal ensures
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that AID protein is primarily sequestered in the cytoplasm, thus limiting the amount of
deamination activity that can access transcriptional substrates in the nucleus (Ito et al.,
2004; McBride et al., 2004). The protein is further regulated by phosphorylation, which
does not alter AID catalytic activity, but may instead create docking sites for downstream
factors involved in SHM or CSR (Basu et al., 2005; Basu et al., 2007; Basu et al., 2008;
McBride et al., 2006; McBride et al., 2008; Pasqualucci et al., 2006; Vuong et al., 2009).
AID ubiquitination has also been described, though it remains unclear if this modification
regulates proteasomal degradation of AID or its interaction with co-factors (Aoufouchi et
al., 2008). AID-interacting proteins are proposed to play roles in inter-locus (Ig versus
non-Ig genes) and intra-locus (V versus C region) targeting, locus-specific assembly of
multi-protein complexes that differentially promote SHM or CSR (Chaudhuri et al.,
2004; Conticello et al., 2008; MacDuff et al., 2006), or even negative regulation of AID
to prevent ectopic mutation of non-Ig loci and lymphomagenesis (McBride et al., 2004;
Ta et al., 2003).
This combinatorial demarcation of functional boundaries for AID serves as an
excellent example of the complex information flow generated through gene expression
and regulation. I have expanded on this molecular network of AID “supervisors”, with
the identification of a new contributor to AID regulation: microRNA-155 (Teng et al.,
2008).
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CHAPTER 2: microRNA-155 is a negative regulator of AID

2.1 mIR-155 is upregulated in B lymphocytes undergoing class switch recombination
Animal miRNAs predominantly function as fine-tuners of gene expression with
the capacity for coordinate regulation of groups of genes. My objective was to identify
miRNAs that regulate CSR in this manner. Thus I profiled the miRNA expression
patterns in naïve and class-switching B lymphocytes by small RNA cloning and
sequencing. These data have been catalogued in the smiRNAdb database of tissuespecific mammalian miRNA expression profiles (Landgraf et al., 2007). Of the 123
miRNAs that were cloned from these samples (data not shown), I identified one, miR155, that was upregulated after stimulation (Fig. 8a). By my analysis, this was the sole
miRNA upregulated in class switching B lymphocytes. Furthermore, miR-155 was
upregulated not only in primary splenic B cells treated with LPS and IL-4 (which induce
switching from IgM to IgG1), but also in CH12-F3 cells, a murine B cell line which
switches from IgM to IgA after treatment with anti-CD40, IL-4, and TGF-β (Fig. 8b).
Thus, miR-155 expression is induced during CSR in manner that is not isotype-specific.
miR-155 is well conserved in the animal lineage, having been identified in sea
squirts, fish, frogs, and mammals (Griffiths-Jones et al., 2008). In humans and mice,
miR-155 is prominently expressed in many hematopoeitic cell types (Landgraf et al.,
2007), and several complementary studies over the last few years have implicated miR155 as a key protagonist in diverse immune processes. However, the details of miR-155
function in immunity (i.e. its direct targets) had not been described at the time of this
work.
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The gene encoding this microRNA was first identified as a preferential retroviral
integration site in chicken lymphomas (Clurman and Hayward, 1989). This novel protooncogenic locus was dubbed bic, for B cell integration cluster (Clurman and Hayward,
1989). Retroviral activation of bic was correlated with myc activation and tumor
metastasis. Homologs of bic were later identified in mouse and human (Tam, 2001), but
the functional significance of bic remained unknown for some time, as the gene lacked
conserved open reading frames. The most conspicuously conserved feature in the Bic
RNA was a predicted double-stranded foldback motif, which would later be recognized
as the precursor hairpin encoding miR-155 (Eis et al., 2005; Tam, 2001).
Similar associations between Bic/miR-155 expression and certain human B cell
cancers began to emerge: Bic/miR-155 is highly overexpressed in lymphomas of
activated-B cell origin, including Hodgkin’s lymphoma (Kluiver et al., 2005; van den
Berg et al., 2003) and diffuse large cell B-cell lymphoma (Eis et al., 2005; Kluiver et al.,
2005). These correlational observations were complemented by the work of Croce and
colleagues, who created transgenic mice overexpressing miR-155 in B cells (Costinean et
al., 2006). These mice developed pre-B cell lymphoproliferative disorders, which later
progressed to full B cell lymphomas. These oncogenic effects are not exclusive to the
lymphoid lineage, as elevated miR-155 expression is also detected in the bone marrow of
patients suffering from acute myeloid leukemia (O'Connell et al., 2008). Overexpression
of miR-155 in hematopoeitic stem cells in the mouse resulted in gross expansion of
myeloid lineages in the bone marrow and peripheral blood at the expense of erythroid and
lymphoid populations. Together, these results reveal the dark side of miR-155 function –
tandem downregulation of gene set, leading to hyperproliferation and disease.
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Despite the oncogenic hazards of deranged miR-155 expression, this microRNA
has clear utility in the context of healthy innate and adaptive immune systems. Those
who first described Bic observed low expression of Bic in hematopoeitic and lymphoid
organs of healthy chickens, suggesting some kind of inherent function outside of
oncogenesis (Tam et al., 1997). As the miRNA field came to prominence, several groups
noticed that mature miR-155 was induced upon activation of murine myeloid and
lymphoid cell types (Haasch et al., 2002; O'Connell et al., 2007; Rodriguez et al., 2007;
Teng et al., 2008; Thai et al., 2007; Tili et al., 2007). Mice deficient in miR-155 show
clear defects in Ig production and maturation, exhibiting reduced overall titers of serum
Ig, and specifically, decreased titers of high-affinity and class-switched hapten-specific Ig
(Rodriguez et al., 2007; Thai et al., 2007; Vigorito et al., 2007b). These B-lymphocyte
defects, along with faulty antigen presentation by dendritic cells and disturbed T
lymphocyte maturation, contributed to the complex immunodeficiency exhibited by the
miR-155-deficient animal, which was unable to generate immunological memory, and
could not protect itself from repeated infections with the same pathogen (Rodriguez et al.,
2007). Transcriptome profiling revealed that approximately 60 putative miR-155 target
genes were upregulated in these mice compared to wild type counterparts (Vigorito et al.,
2007b). At the time of this work, however, none of these potential targets had been
specifically characterized with respect to miR-155 regulation and Ig maturation.

2.2 miR-155 targets the 3’UTR of AID mRNA
Since I had observed miR-155 induction in class-switching B lymphocytes, my
next objective was to understand how miR-155 contributes to Ig diversification. I applied
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several miRNA target prediction algorithms (PicTar (Krek et al., 2005), miRanda
(Griffiths-Jones et al., 2006; John et al., 2004), and TargetScan (Grimson et al., 2007;
Lewis et al., 2003)) to identify putative targets of miR-155 with relevance to either SHM
or CSR. These prediction algorithms tend to return copious lists of putative miRNA
targets, but AID was consistently predicted as one such target. Furthermore, the stringent
prediction criteria of the TargetScan algorithm (Grimson et al., 2007) identified miR-155
as the sole miRNA target site in the AID 3’UTR. The 3’UTRs of AID mRNA diverge
substantially in sequence and length between various species (Fig. 8c). However, they
coincide strikingly at an 8 nucleotide motif corresponding to the predicted miR-155 target
site seed region. To test the possibility of post-transcriptional AID regulation by miR155, I created reporter constructs containing the 3’UTR of AID downstream of a firefly
luciferase reporter gene (Luc-UTR), along with variants harboring deletion (Luc-delUTR) or mutation (Luc-mut-UTR) of the miR-155 target site (Fig. 8d). These constructs
were transiently transfected into CH12-F3 cells stimulated to undergo CSR (and hence
induced to express endogenous miR-155). I observed repression of luciferase activity by
~50% in cells transfected with Luc-UTR compared to cells transfected with a luciferaseonly construct (Fig. 8e). This repression was alleviated upon disruption of the miR-155
target site by deletion or mutation. These data indicate that the single target site in the
3’UTR of the AID mRNA renders it susceptible to repression by physiological levels of
miR-155 expressed during CSR.
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2.3 Mutation of the AID miR-155 target site results in deregulated AID expression
and increased CSR
To study the behavior of in vivo AID expression in response to miR-155, I took
advantage of a recently generated transgenic AID-GFP indicator mouse strain (Crouch et
al., 2007). These mice carry a 75 kilobase-long BAC that contains the entire AID locus as
well as its two adjacent gene loci (Mfap5 and Apobec1). The AID locus in this BAC has
been modified such that the gene encoding GFP is inserted immediately downstream of
the coding portion of the final AID exon (Fig. 9a). The transgenic AID-GFP fusion
protein expressed from this BAC was previously shown to replicate endogenous patterns
of AID expression (Crouch et al., 2007). The AID-GFP protein also retains catalytic
activity, as it can rescue in vitro CSR in AID-/- B lymphocytes (data not shown). Based
on this published AID-GFP BAC, I created a second transgenic construct in which the
miR-155 target site seed region was mutated to disrupt binding to miR-155 (AID-GFPMut) (Fig. 9a). This second construct was used to generate five independent founder lines
carrying the AID-GFP-Mut BAC transgene.
Splenic B lymphocytes from progeny of these transgenic founders were analyzed
for AID-GFP expression in response to in vitro stimulation with IL-4 and LPS. The
dynamics of AID-GFP expression differed considerably between the AID-GFP control
and AID-GFP-Mut mice. The controls exhibited a gradual increase of low intensity AIDGFP fluorescence with time of stimulation (as also observed in (Crouch et al., 2007)),
mirroring the expression profile of endogenous AID. In contrast, cells from AID-GFPMut mice showed a rapid induction of AID-GFP, peaking early around day 3, then
reaching a plateau (Fig. 9b). The median intensity of AID-GFP fluorescence was also
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higher in the AID-GFP-Mut mice, suggesting more abundant AID-GFP protein,
compared to controls (data not shown). Similar trends were also observed for AID-GFP
mRNA, suggesting that miR-155 could regulate AID mRNA stability and protein
translation (Fig. 9c). My results demonstrate that in vivo disruption of the AID miR-155
target perturbs the quantitative and temporal expression characteristics of AID.
These disparities were not due to position effects due to differential integration of
each BAC transgene since large BACs are not susceptible to overexpression due to
random insertion in active expression sites (Gong et al., 2003; Hatten and Heintz, 2005).
Furthermore, I screened multiple independent AID-GFP-Mut founder lines, and also
controlled for copy number variation by comparing animals with similar transgene copy
numbers – in all instances yielding identical results (data not shown).
To assess the functional consequences of miR-155 target site disruption, the AIDGFP control and AID-GFP-Mut mice were bred onto an AID-/- background to extinguish
the contribution of endogenous AID. I first compared in vitro CSR efficiency by
stimulating splenic B lymphocytes from these mice using LPS (to induce CSR to IgG3),
LPS and IL-4 (to induce CSR to IgG1), or LPS and IFNγ (to induce CSR to IgG2a).
AID-/- B cells perform negligible in vitro CSR (data not shown). I observed increased
CSR in the AID-GFP-Mut mice compared to AID-GFP control or wild type mice (Fig.
9d). This was the case regardless of whether these BAC transgenics were deficient or
heterozygous for AID in the endogenous locus (Fig. 9d). These results indicate that miR155 directly regulates AID expression in stimulated B lymphocytes.
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2.4 Mutation of the miR-155 target site leads to local but not global deregulation of
AID in vivo
To study in vivo effects of disrupting the AID miR-155 target site, the transgenic
mice were immunized intraperitoneally with nitrophenol conjugated to chicken gamma
globulin (NP-CGG). The NP hapten induces a well-characterized immune response in
peripheral lymphoid germinal centers (GC), where activated lymphocytes undergo Ig
diversification (Cumano and Rajewsky, 1985; Furukawa et al., 1999; Taketani et al.,
1995). Eighteen to 21 days after immunization, I evaluated AID-GFP expression by flow
cytometry in various B lymphocyte subsets. Mutation of the miR-155 target site did not
disrupt global transcriptional control of AID: immature CD93+ B lymphocytes in the
bone marrow, along with thymic and peripheral CD4+ or CD8+ T lymphocytes were
devoid of AID-GFP (Fig. 10). However, AID-GFP was detected in B cell populations
associated with activation. GC B lymphocytes (CD95+ B220+) from spleen and intestinal
Peyer’s patches expressed AID-GFP in both the control and AID-GFP-Mut mice. The
latter, however, showed far more intense GFP fluorescence, indicating a similar
overabundance of AID-GFP during the GC reaction, as observed during in vitro CSR
(Fig. 11a).
After completing the GC reaction, activated B lymphocytes exit into the periphery
and differentiate into plasma or memory cells. These post-GC B lymphocytes cease to
express AID (Crouch et al., 2007). Accordingly, the AID-GFP control mice did not
express AID-GFP in B cells in the peripheral blood (Fig. 11b). In contrast, a GFP+
population of B cells was consistently detected in the blood of immunized AID-GFP-Mut
mice (Fig. 11b). These appeared to be a heterogeneous population of B lymphocytes
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(B220int-hi), which were mostly IgG1+ but also included IgM+ and IgD+ non-switched
cells. This B lymphocyte population did not appear to arise ectopically as a consequence
of AID-GFP overexpression, as a similar B220int (though GFP–) population was also
present in the AID-GFP controls. Thus, disruption of the AID miR-155 target site allows
for improper persistence of AID-GFP expression beyond the GC compartment. These
results confirm once again that the phenotypes I observed cannot be explained by BAC
copy number variation, which could be expected to increase protein expression but
cannot lead to persistent expression in cells where the gene of interest is normally shut
off. My data strongly support the idea that miR-155 controls AID expression levels and
specifically, plays a pivotal role in extinguishing AID expression in post-GC B cell
populations.

2.5 Loss of miR-155 regulation of AID results in impaired affinity maturation
To determine the functional impact of defective AID downregulation, I compared
affinity maturation of NP-binding IgG1 in sera collected at 8 days and 19 or 21 days after
immunization. The ELISA capture substrate was NP conjugated to BSA in different
ratios to detect high-affinity (NP3-BSA) and total (NP30-BSA) immunoglobulins (Ig)
specific for NP. Affinity maturation was measured as the NP3:NP30 -binding ratio. As
expected, I observed an increase in the proportion of high-affinity Ig from day 8 to
day19/21 in control AID-GFP mice. However, affinity maturation was significantly
impaired in AID-GFP-Mut animals (Fig. 12).
To ascertain if the observed affinity maturation defect resulted from AID-GFP
overexpression in GCs, I analyzed the mutation load at Ig loci in CD95+ GC B
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lymphocytes. After sequencing the VH186.2 gene segment, which is selected for during
the Ig response against NP (Cumano and Rajewsky, 1985) (to assess the mutation profile
under selection) and the JH4 intron (to assess the mutation profile in the absence of
selection pressure), I found that the frequencies and overall patterns of mutation did not
differ substantially between AID-GFP and AID-GFP-Mut mice (Table 1). Thus, I
considered two possibilities: either the repair mechanisms that process AID-mediated
lesions are not overwhelmed by higher lesion loads, or excess AID was not specifically
targeted to the Ig locus.
Aside from the Ig genes, a number of other genes, including the oncogene Bcl6,
have been shown to hypermutate in germinal centers (Pasqualucci et al., 2001; Shen et
al., 1998). I reasoned that excess AID mutational activity, if not targeted to the Ig genes,
could instead be targeted to these other non-Ig loci. To test this hypothesis, I cloned and
sequenced Bcl6 from GC B lymphocytes of NP-immunized AID-GFP and AID-GFP-Mut
mice. I found that Bcl6 from AID-GFP GC B cells was mutated with a frequency of 0.17
x 10-3 per base (similar to reported Bcl6 mutation frequency in murine GC B cells from
Peyer’s Patches (Muto et al., 2006) (Table 1). In contrast, Bcl6 from AID-GFP-Mut GC
B lymphocytes mutated about three times as frequently (0.46 x 10-3 per base) (Table 1).
This observation supports the hypothesis that excess AID activity within the GC is
distributed to non-Ig targets for hypermutation, suggesting that loss of miR-155-mediated
downregulation of AID could result in higher rates of AID-dependent translocation or
lymphomagenesis.
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Table 1. In vivo mutation frequencies in AID-GFP and AID-GFP-Mut mice

Genotypea
AID-GFP

VH186.2
31.8
(394/12,400)b

JH4 intron
6.8
(79/11,600)

Bcl6
0.17
(7/41,600)c

30.7
5.5
(800/26,000)
(101/18,400)
a
Mutation data are pooled from two animals
b
(number of point mutations / total nucleotides sequenced)
c
Chi square test, P=0.0306

0.46
(18/39,000)

AID-GFP-Mut

Mutation frequencies x 10–3 per base (accumulated number of mutations in a given region
divided by the total number of nucleotides sequenced from that region) are shown for
VH186.2, JH4 intron, and Bcl6 from splenic GC B cells in NP-immunized AID-GFP and
AID-GFP-Mut mice.
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Table 2. Clonal variability in post-GC B lymphocytes of AID-GFP and AID-GFP-Mut
mice

Genotypea

# unique clones / total

AID-GFP

9/50c

Intraclonal mutation
frequency x 10-3
0.55 (11/20,000)b

%W33L or Y99Gd

AID-GFP-Mut
36/80c
0.87 (34/39,000)
a
Mutation data represent unique clones pooled from four animals
b
(number of point mutations / total nucleotides sequenced)
c
Fisher’s exact test for the indicated data sets, P=0.043
d
W33L and Y99G are substitutions associated with high affinity
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Clonal variability is expressed in terms of clonal mutations in the JH4 intron and amino
acid substitutions associated with NP antibody affinity maturation.
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However, these data did not explain the loss of affinity maturation observed in the
AID-GFP-Mut mice. I then asked if continued mutation outside of the GC (due to
persistent AID-GFP expression in post-GC B cells) could account for this phenotype. To
test this possibility, I cloned and sequenced the JH4 intron from post-GC lymphocytes
from peripheral blood of AID-GFP and AID-GFP-Mut mice. I found that B lymphocytes
from the blood of AID-GFP mice comprised a small number of highly related and
affinity-matured clones, with some intraclonal heterogeneity (Table 2). This is not
surprising, as post-GC B cell clones in the blood have undergone stringent positive
selection for those producing high-affinity Ig. In contrast, I found a higher number of
unique post-GC B lymphocyte clones in the blood of AID-GFP-Mut animals. Because
these clones were so heterogeneous, I could not conclusively ascertain if the mutational
load per unique clone was higher in comparison to those from the blood of AID-GFP
mice (i.e., whether these cells were continually mutating their JH4 intron). However, in
agreement with the serum data, these clones did not appear to have acquired the amino
acid substitutions associated with high affinity NP antibodies (notably the W33L
substitution or the Y99G substitution (Furukawa et al., 1999)). Two non-mutually
exclusive explanations could account for these results: 1) selection remains intact in the
GC to allow for emergence of high affinity B lymphocyte clones, but continued mutation
in the outside of the GC diminishes the affinity of the previously-selected clones, or 2)
overabundant AID expression in the GC somehow disturbs the process of selection, and
allows the escape of low affinity Igs from the GC.
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2.6 Discussion
Although hundreds of miRNAs are present in the mammalian genome, genetic
studies addressing their physiological roles are at an early stage. Here, I address the
function of miR-155 in the context of antibody diversification by identifying this
particular miRNA as upregulated in B cells undergoing CSR, by bioinformatically
identifying AID as a putative target, and by genetically mutating the target sequence in
the 3’UTR of the AID mRNA to allow the resulting mRNA to escape miR-155 control.
These experiments were the first to identify a target of a miRNA in vivo, not by
manipulating expression of the miRNA itself, but rather, by genetically disrupting the
association between a miRNA and its target.
Most miRNA-targeted mRNAs contain multiple predicted target sites for several
different miRNAs. Deletion of just one of these targeting miRNAs can result in target
upregulation in a dose-dependent manner, leading to the hypothesis that multiple
microRNAs synergistically fine-tune the expression of a single target gene (Xiao et al.,
2007). There is also a remarkable degree of regulatory cooperativity between closelyspaced microRNA target sites (Grimson et al., 2007). Surprisingly, stringent target site
predictions for the AID 3’UTR identify only a single miRNA target site complementary
to miR-155. Mutating the seed region of this site leads to dramatic RNA and protein
overabundance and disruption of proper temporal downregulation. My observations are
consistent with the miR-155-/- mouse phenotype [reported by two independent groups as
my own work was in progress (Rodriguez et al., 2007; Thai et al., 2007)], which also
featured increased AID expression (though to a lesser degree than observed in my
transgenic mouse model) (Vigorito et al., 2007a). The behavior of the transgenic AID-
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GFP-Mut RNA and protein strongly supports a model in which miR-155 directly
downregulates AID expression. In this particular case, AID protein amounts and activity
are already limited by haploinsufficiency combined with multi-factorial regulation.
Superimpose this regulatory network with a “subtle” suppressor such as miR-155, and the
effects of a single miRNA could be far more substantial than anticipated. One could
imagine a very fine tipping point between AID expression and repression, and
temporally, miR-155 could provide the regulatory impetus that biases the system towards
extinguishment, ensuring an optimal immune response.
Ablating miR-155 control of AID expression led to increased RNA and protein
expression in switching cells, which underwent significantly higher levels of CSR. The
de-repressed AID-GFP protein in germinal center lymphocytes, however, did not produce
elevated SHM frequency in the Ig locus, instead causing increased hypermutation of a
non-Ig locus, Bcl6. This is consistent with previous work by Honjo and colleagues (Muto
et al., 2006), who likewise showed that transgenic AID overexpression does not lead to
an increase in SHM. One can infer from these combined results that: 1) there are
fundamental differences in targeting of AID to the V region genes versus the C region
genes, and 2) SHM may involve a limiting factor that shields potential deamination
targets in the Ig locus from excess AID activity.
Excess AID is likely to increase the rates of chromosomal translocations
associated with errant hypermutation (Dorsett et al., 2008; Ramiro et al., 2006; Ramiro et
al., 2004). In the absence of miR-155 control, AID overexpression may be causal for B
cell lymphomagenesis. Indeed, Kluiver et al. have recently documented a lack of miR155 expression in primary cases of B cell Burkitt lymphomas, which constitutively
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express AID (Kluiver et al., 2006).
In addition to overabundance of AID, I have shown that lack of miR-155 control
leads to persistence of AID expression in post-germinal center B cells, effectively
marking a unique subset of circulating B cells as recent emigrants from the germinal
center. I also find that persistent AID expression is associated with specific defects in
affinity maturation. It is possible that persistent AID expression supports ongoing
mutation in the Ig locus well after cells exit the germinal center with an affinity-matured
antigen receptor, effectively destroying the properly selected Ig repertoire. However, one
might expect to observe a much larger increase in clonal heterogeneity in peripheral B
cell populations, if this were the case. Alternatively, my observation of multiple lowaffinity B cell clones in the blood of AID-GFP-Mut animals could suggest a defect in
positive selection of properly matured B cells. Though the mechanisms of positive
selection and affinity maturation are not well understood, it is thought that B lymphocytes
cycle between the dark zone of the germinal center, where mutation occurs, to the light
zone, where their newly minted receptors are substrates for positive selection.
Eventually, B cells bearing high-affinity Igs are thought to emerge after multiple rounds
of recycling through the germinal center. My data would support a scenario where B
cells overexpressing AID may not be allowed to “recycle” into a germinal center for
proper affinity maturation. This would require some mechanism for cellular sensing of
AID expression that would form a feedback loop between proper AID extinction and GC
cycling. Particularly if AID forms long-lived complexes on its transcribed DNA
substrates, one could imagine that funneling of free-floating DNA repair factors onto an
assembling stable AID mutasome could provide one means of stochiometric “counting”
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of AID molecules. Coupling of DNA repair to cell cycle and cell proliferation perhaps
then informs the choice between continued GC recycling and competition for GC exit.
Alternatively, thresholds of DNA damage at non-Ig targets of AID mutagenesis could
serve as proxy read-outs of AID activity. Perhaps these cycling lymphocytes can only
tolerate so much collateral damage (whether in the form of generalized DNA damage or
functional effects specific to mutation of these non-Ig loci) before they are shunted
towards GC exit. In either of these scenarios, excess AID activity could overwhelm the
ability of the system to accurately recognize and release high affinity B lymphocytes.
This, however, remains pure speculation as little is presently known about the cellular
and molecular parameters governing the mechanism of proper selection and affinity
maturation.
The complex immunodeficiency of the miR-155 deficient mouse highlights the
immense contribution of miR-155 to various aspects of vertebrate immunity (Rodriguez
et al., 2007; Thai et al., 2007). These mice exhibited modest increase in AID expression,
decreased in vivo CSR to IgG1, and impaired affinity maturation – likely reflecting the
composite deregulation of at least sixty miR-155-responsive mRNA targets (Vigorito et
al., 2007a). In contrast to global ablation of miR-155 regulation, I have described the
specific disruption of a single miR-155 – s target interaction. In our transgenic mouse
model, I observed robust deregulation of AID-GFP expression, increased in vitro CSR,
and impaired affinity maturation – some of which may not be apparent in the context of
total miR-155 deficiency. Of the deregulated mRNA targets in the miR-155-/- mouse,
only two have been examined in any detail with respect to miR-155 regulation: AID, and
the transcription factor Pu.1 (Vigorito et al., 2007a). The challenge in coming years will
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be to validate the entire suite of predicted targets, and integrate this knowledge to
understand how a single miRNA can coordinate an intricate immune response.
As a central catalyst for immunoglobulin diversification, AID is regulated by
networked transcription factors, intracellular trafficking, and protein modifications. I
have described an additional miRNA-mediated pathway of AID regulation, which
controls AID expression in germinal center B cells and ensures proper extinction of AID
expression as cells affinity mature and exit the secondary lymphoid organs. Thus, miR155 plays an important role in the molecular restraint of AID, an enzyme that confers
great immunological benefit, but must be tightly regulated to limit its mutagenic and
oncogenic potential.
The AID miR-155 target site, a relatively miniscule regulatory motif, has been
evolutionarily maintained amidst a sea of highly divergent 3’UTR sequence – all the way
from bony fishes to humans. The conservation of this site almost parallels the
phylogenetic origins of AID itself, which dates to cartilaginous fishes (Conticello et al.,
2005). This suggests an ancient, but stringently selected role for miR-155 in regulating
AID expression. Recent deep sequencing approaches in simple non-bilaterian animals
reveal that miRNA function extends deep into animal phylogeny, serving as a primordial
mechanism of post-transcriptional gene regulation (Grimson et al., 2008). Conjecturally,
AID’s first appearance in the evolutionary record was likely followed by the rapid
acquisition of a regulatory miR-155 target site. As the immunoglobulin genes co-evolved
sequence motifs amenable to AID deamination (Jolly et al., 1996; Kepler, 1997; Wagner
et al., 1995), sequentially giving rise to SHM, then CSR, the reach of miR-155 regulation
eventually extended to adaptive immunity.
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Control of miR-155 expression itself is an important factor, given the substantial
impact of miR-155 function on human health. Reportedly, AP-1 and NF-κB binding
sites provide transcriptional control over Bic, but the definitive set of transcriptional
regulatory factors for the gene is not known (O'Connell et al., 2007; Yin et al., 2008a;
Yin et al., 2008b). Bic RNA undergoes co-transcriptional processing (splicing and
differential polyadenylation), which may also exert as-yet undefined effects on miR-155
expression (Tam, 2001). In addition, miR-155 is intriguing from a general perspective of
miRNA biogenesis, as defects in processing of mature miR-155 from Bic have been
observed in certain B cell lines (Kluiver et al., 2007). This may indicate the existence of
general control mechanisms for miRNA biogenesis that are differentially manipulated in
healthy and diseased cell states.
Case-by-case validation of individual miRNA targets, while enormously
informative, must be supplemented with “big picture” perspectives of miRNA function.
Bioinformatic approaches have driven, and should continue to drive this outlook on
miRNA biology, as diverse data sets from target prediction algorithms, miRNA
expression atlases, and tissue-specific transcriptome or proteome profiles become
accessible in cross-referenced form. As a representative example, miR-155 expression is
relevant to native immune responses, as well as diverse types of cancers (Eis et al., 2005;
Gironella et al., 2007; Kluiver et al., 2005; van den Berg et al., 2003; Volinia et al., 2006)
and viral infection (Gottwein et al., 2007; Skalsky et al., 2007). Comparisons between
miR-155 specific sets of co-regulated gene could be incredibly useful in understanding
the expression patterns that determine the balance between healthy and pathological
function.
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When the first miRNAs were characterized in nematodes, none could have
predicted that tiny chains of ribonucleotides could exert such significant influence over
gene expression throughout evolution and throughout the living world. We now
understand that miRNAs establish intricate webs of regulation, where single targets are
often combinatorially targeted by multiple miRNAs, and conversely, most miRNAs
regulate multiple targets (Lim et al., 2005). With the emergence of complex
physiological systems in higher organisms, ancient mechanisms of miRNA regulation
have networked with newer mechanisms of transcriptional, post-transcriptional, and posttranslational regulation to create nuanced temporal and spatial patterns of gene
expression in diverse cell types. Here I have presented a specific example where one
miRNA contributes substantially to immunoglobulin gene diversification and adaptive
immunity.
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CHAPTER 3: Noncoding RNAs in cis

In addition to the undoubtedly extensive network of miRNA control during Ig
diversification, there are tantalizing hints that long ncRNAs may also influence CSR in
cis. As the unrearranged (or germline) constant region genes become activated for DNA
recombination, they undergo premature noncoding transcription (Fig. 13a). The sterile
read-through initiates from the Ig heavy chain enhancer (Eµ) for the Cµ region, or from
independent promoters located in each of the downstream C regions; then traverses a
noncoding exon (I), the S region, and the C region exons. The transcript subsequently
undergoes splicing to remove the intronic S region and the C region introns. Site-specific
germline transcription (GLT) invariably precedes the induction of CSR to a particular
constant region (Gerondakis, 1990; Lebman et al., 1990; Lutzker and Alt, 1988; Lutzker
et al., 1988; Radcliffe et al., 1990; Rothman et al., 1990a; Rothman et al., 1990b;
Stavnezer et al., 1988; Xu and Stavnezer, 1990). Stop codons litter all three reading
frames of the I exons, so the transcripts are unlikely to retain any protein-coding capacity.
Furthermore, B lymphocytes harboring a heterologous sequence in place of the I exon
can still potentiate CSR (Harriman et al., 1996; Qiu et al., 1999). However, mutation or
deletion of the germline promoters leads to CSR defects, indicating that either the process
of transcription, or the noncoding RNA itself is functionally important (Bottaro et al.,
1998; Jung et al., 1993; Zhang et al., 1993).
One aspect of GLT function may relate to creation of accessible single-stranded
DNA substrates for AID, whether in the context of a transcriptional bubble, or a
transcription-independent R-loop: G-rich RNA hybridized to its cognate DNA. The
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G/C-rich S regions are supremely amenable to the formation of such structures, and
indeed, there is some evidence of R-loops arising in mammalian S regions (Daniels and
Lieber, 1995; Mizuta et al., 2003; Reaban and Griffin, 1990; Reaban et al., 1994; Yu et
al., 2003). The G/C-poor S regions of Xenopus, however, are still capable of mediating
CSR, suggesting that R-loop dependent mechanisms of regulating substrate accessibility
may have manifested recently in evolution. Thus, the magnitude of R-loop contribution
in CSR is uncertain. It is unknown how an in vivo R-loop at the S region would be
resolved, and if this model would be consistent with the kinetics of GLT splicing (since
the S region is excised as an intron, and presumably degraded rapidly). In addition, the
C-rich strand of the S region, incapable of forming an R-loop, would require a distinct
mechanism to generate single-strandedness.
Alternate functions for GLT may be proposed based on its known characteristics.
Given that S region DNA is highly repetitive and palindromic, an RNA transcribed from
the S region, regardless of transience, would likely harbor secondary structures such as
double stranded stem-loops. A possibility I considered was the production of small guide
RNAs from the pre-spliced GLT. Conceivably, double stranded RNA motifs could be
recognized and processed by RNAi machinery to generate sequence specific guides that
recruit downstream protein effectors for CSR. As I scanned my small RNA cloning data
from class switching B lymphocytes, I found no evidence to support this hypothesis (data
not shown). I cannot, however, exclude the possibility of S-region derived small RNAs
outside of the canonical siRNA size range.
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To query the general transcriptional accessibility of the unrearranged C regions, I
assayed for transcripts arising from both strands. Surprisingly, low abundance antisense
transcripts accompanied sense GLT, initiating from heterogeneous start sites (Fig. 13b).
These unpublished observations agree quite well with those reported by Alt and
colleagues (Perlot et al., 2008). A similar process of intergenic antisense transcription
also occurs in the upstream variable regions prior to V(D)J recombination, and has been
proposed to facilitate DNA recombination by modulating chromatin accessibility
(Bolland et al., 2004). Currently, I can only speculate on the functional significance of
this bidirectional transcription. The 5’ heterogeneity and the low abundance of the
antisense transcripts relative to their sense counterparts suggest that: 1) antisense
transcription depends on prior sense transcription, 2) the antisense transcript may not
reflect an active promoter-driven process of transcription, 3) the antisense transcript may
be highly unstable, rapidly degraded, or rapidly processed to disallow accumulation. One
can imagine functional scenarios consistent with a transiently available antisense species.
Rapid annealing of sense and antisense RNA could form a duplex to be processed into
guide RNAs in an RNAi-independent fashion. Alternatively, duplexing between the two
transcripts, followed by degradation could provide a means of regulating sense GLT
abundance. This would be important in the case of a quantitative relationship between
CSR and GLT – which so far, is not clear. Finally, bidirectional transcription may be
relevant from the perspective of locus mechanics. Perhaps convergence of two RNA
polymerases travelling in opposite directions could create transcriptionally paused S
region substrates amenable for AID activity.
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Clearly, many questions have yet to be resolved on the issue of germline
transcription, regardless of orientation. The temporal extent to which this phenomenon
precedes functional CSR suggests some sort of preparatory significance, perhaps with
implications for targeting of AID activity or double strand break repair activity. The role
of RNA processing, in particular, remains a mystery. In vivo experiments have
previously demonstrated that genetic ablation of I exon splice donor sites can severely
hinder CSR (Hein et al., 1998; Lorenz et al., 1995). The co-transcriptional processing of
nascent GLTs – capping, splicing, and polyadenylation – may function outside of direct
RNA maturation, and instead allow for secondary recruitment of downstream factors.
For example, the RNA polyadenylation complex has recently been shown to interact with
DNA repair factors such as Ku70 and DNA-PK, which are key to end joining in CSR
(Shi et al., 2009). One could imagine similar role for the spliceosome, an enormous
multi-protein complex that includes many subunits not directly involved in RNA splicing
(Zhou et al., 2002). Thus, early noncoding transcription prior to CSR could pre-assemble
proteins involved in DNA break repair or end joining at the Ig locus. Alternatively, the
GLT itself may potentially attract protein partners independently of co-transcriptional
RNA processing, acting as a recruitment platform for RNA-binding proteins and
associated factors that could promote locus accessibility or downstream reactions in CSR.
Byproducts of splicing could also be functionally important in this context. Occasional
examples of highly stable introns have been reported (Clement et al., 2001; Clement et
al., 1999), so with regard to the Ig locus, a long-lived intronic S region RNA could form a
highly structured guide RNA, or even support stable R-loop formation at the S region
DNA. I am currently investigating several of these testable hypotheses.
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In recent years, extended noncoding transcription has been observed on a
genome-wide scale, with signs of evolutionary conservation (Guttman et al., 2009).
Computationally, these sites tend to cluster with genes involved in transcriptional
regulation, and are unlikely to represent transcriptional noise. Widespread bidirectional
transcription has also been identified, representing at least two distinct phenomena. The
mammalian transcriptome includes copious numbers of coordinated sense and antisense
transcript pairs (Chen et al., 2004; Katayama et al., 2005; Kiyosawa et al., 2003; Yelin et
al., 2003), where antisense interference may generally regulate abundance of the sense
strand. Recently, a separate observation of diverging bidirectional transcription has been
made at promoters of active genes (Core et al., 2008; He et al., 2008; Preker et al., 2008;
Seila et al., 2008; Xu et al., 2009), and is proposed to influence promoter regulation and
accessibility. Germline transcription appears to incorporate aspects from each of these
newly described processes, which may inform our conception of how GLT contributes to
CSR. Given the unexpected ubiquity of long ncRNAs in the mammalian transcriptome, I
expect that GLT may indeed serve as one representative example of how long ncRNAs
can modulate gene accessibility, targeting, or regulation.
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CHAPTER 4: Perspective

Here I have described examples of RNA-mediated regulation of the
immunoglobulin gene locus – modulated by noncoding RNAs, both large and small. Far
from mere relics of an archaic RNA world, regulatory ncRNAs have proven to extend
RNA function past simple information transfer between DNA and protein. These RNAs
show exquisite specificity, as they scan the transcriptome in a sequence-dependent
manner; as well as functional cooperativity, as they collaborate with RNA-dependent and
RNA-independent regulatory mechanisms. One can easily recognize how RNA, as a
primordial bio-polymer, would embody all the necessary qualities – genetic storage,
catalytic activity, and regulatory activity – to maintain and propagate organic life in the
RNA world (Gilbert, 1986; Woese, 1967).
These interconnected stories of noncoding RNA regulation in Ig diversification
testify to a simple truth reiterated endlessly in the scientific literature: a genome is more
than the sum of its parts. As coded information passes linearly from gene to functional
protein, that information can undergo astonishing amounts of editing – whether in the
form of somatic DNA alterations (as in Ig diversification), direct regulation by protein
co-factors (for example, deamination of Ig DNA by AID), direct regulation by noncoding
RNAs (such as Ig germline transcripts), or secondary regulation (for example, miR-155mediated repression of AID). As these cycles of gene expression and regulation
propagate in every cell type, in every organism, one can appreciate the awesome
complexity that has developed through the evolutionary continuum from the very first
self-replicating biological molecules all the way to sentient life.
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CHAPTER 5: Materials and Methods

B lymphocyte isolation and cell culture.
CD43– naïve splenic B lymphocytes were purified by magnetic separation (MACS,
Miltenyi Biotec). Cells were maintained at 0.5 - 1 x 106 /ml in standard culture medium,
and were treated with 5 ng/mL IL-4 (Sigma) and 25 µg/mL LPS (Sigma) to induce CSR
to IgG1; 25 µg /mL LPS to induce CSR to IgG3; or 25 µg/mL LPS and 0.5 µg/mL IFNγ
(Sigma) to induce CSR to IgG2a. CH12-F3 cells were maintained in standard culture
medium, and were treated with 5 ng/mL IL-4, 0.2 µg/mL anti-CD40 (eBioscience), and
0.1 ng/mL TGF-β (R&D Systems) to induce CSR to IgA. Cell cultures were sampled at
various time points for FACS analysis or preparation of RNA.

RNA isolation and small RNA cloning.
Total RNA was prepared with Trizol (Invitrogen), and 21-23 nucleotide RNAs were
isolated, cloned, sequenced, and catalogued as previously described (Landgraf et al.,
2007).

RNA blots.
Total RNA (10-20 µg) was run on a 15% TBE-Urea Criterion gel (Bio-rad), and
transferred to Hybond N+ nylon membrane (Amersham Biosciences) by semi-dry
blotting. Membranes were UV-crosslinked and dried. A miR-155 probe (5’ACCCCTATCACAATTAGCATTAA) was prepared by T4 polynucleotide kinase
labeling with γ32P-ATP. Blots were hybridized in Denhardt’s solution or QuickHyb
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(Stratagene) at 50 ºC, and were washed twice with Wash Solution I (5% SDS, 5x SSC),
and twice with Wash Solution II (1% SDS, 1x SSC).

Luciferase assays.
Reporter constructs were modified from the pRL-TK plasmid (Promega). The renilla
luciferase gene was replaced by firefly luciferase (fLuc) to create the Luc construct. The
3’UTR of the AID mRNA was cloned directly downstream of fLuc to create the LucUTR plasmid. This was then altered by Quikchange PCR (Stratagene) to create the LucUTR-Del and Luc-UTR Mut constructs. CH12-F3 cells were co-transfected with a
reporter construct and pRL-TK by Amaxa nucleofection, and were stimulated for CSR as
above. Cells were lysed 48 hours after transfection and the Dual Luciferase Reporter
Assay System (Promega) was used to measure firefly and renilla luciferase activities.

CSR rescue by AID-GFP.
Replication-deficient retroviruses were generated by transfection of 293T cells with
either AID-GFP-pQCXIP or pQCXIP alone, along with pCL-Eco packaging plasmid.
Viral stocks were used to transduce naïve splenic B lymphocytes from AID-/- mice, which
had been stimulated in culture with IL-4 and LPS.

Transgenic mice.
The AID-GFP-Mut BAC was modified from the AID-GFP BAC used to create the
previously described AID-GFP reporter mouse (Crouch et al., 2007) (copy number
ranging from 1-10). Mutation of the miR-155 target site was achieved by homologous
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recombination in bacteria as described previously (Misulovin et al., 2001). Briefly, the
AID miR-155 target site plus ~1 kb flanking sequence on either side (for homologous
recombination) was amplified by PCR from BAC RP24-68I7 (Genbank AC158651)
using the following primers: 5'-GGCGCGCCGGTAAGTCTGCCTGTCTGTCTGCC
and 5'-GCGGCCGCGCGTCATTTCCTTGCCACGG. The PCR product was cloned into
TOPO-pCR4 (Invitrogen). Point mutations in the miR-155 target site were introduced by
Quikchange PCR (Stratagene). The sequence was again amplified with the same primers
as above, and cloned into shuttle vector pLD53.SC.AEB (which also contains the RecA
and SacB genes). After propagation in PIR2 bacteria (Invitrogen), the construct was
electroporated into bacteria carrying the previously-described modified BAC RP24-68I7
containing the AID-GFP locus (Crouch et al., 2007). Cointegrates were selected for in
liquid culture in the presence of ampicillin (for the insert-containing shuttle vector) and
chloramphenicol (for the BAC), during which RecA-mediated recombination occurred
between the BAC and homologous sequences inserted into the shuttle vector. Cultures
were plated on chloramphenicol, and the desired recombination event (introduction of the
modified miR-155 target site into BAC and deletion of the shuttle vector sequence) was
ensured by treating duplicate plates with UV illumination and sucrose to ensure the loss
of the shuttle-vector-encoded RecA and SacB, respectively. Integrity of the newlygenerated AID-GFP-Mut locus was confirmed by sequencing. Generation of the AIDGFP-Mut transgenic founder mice (copy number ranging from 5-20) was performed by
the Rockefeller University Transgenic Services Laboratory, using standard methods.
Transgene copy numbers were estimated by comparison to copy number standards in
Southern analysis. Animals were housed and studied in accordance with institutional
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guidelines.

Quantitative PCR.
cDNA was generated from DNAse-I-treated RNA, and AID-GFP expression was
monitored by quantitative PCR (5’- GACTTGCGAGATGCATTTCGTATG and 5’GCTGAACTTGTGGCCGTTTAC). cDNA samples were normalized by also amplifying
Ku70 (5’- TGCCCTTTACTGAGAAGGTGAC and 5’TGCTGCAGGACTGGATTCTC).

Immunization and ELISA.
Mice were immunized with 100 µg alum-precipitated NP-CGG (Biosearch Technologies)
by intraperitoneal injection. Serum was prepared from peripheral blood collected by
retro-orbital bleed at various time points. Serum dilutions were incubated in NP3-BSA or
NP30-BSA -coated wells of microtiter plates, and NP-specific Ig were detected by ELISA
using reagents from Southern Biotechnologies Clonotyping System-HRP. Affinity
maturation was calculated as the ratio of NP3-binding (high affinity anti-NP Ig) to NP30binding (total anti-NP Ig).

FACS analysis.
Cell suspensions from bone marrow, spleen, Peyer’s patches, thymus, and peripheral
blood were prepared and stained for FACS using standard procedures. The following
reagents were used to stain cells for FACS analysis (all are from BD Biosciences except
where indicated): CD93-PE (eBioscience), IgM-APC (Jackson Immunoresearch), CD95-

71

PE-Cy7, B220-PerCP, B220-APC, IgG1-biotin, IgM-biotin, IgD-biotin (eBioscience),
CD8-PerCP, CD4-APC, NP-PE (Biosearch Technologies), Streptavidin-PerCP.

Mutational analysis.
Genomic DNA was prepared from sorted splenic germinal center B cells and white blood
cells from peripheral blood. The following were PCR-amplified with PfuTURBO
polymerase (Stratagene): JH4 intron (5'-AGCCTGACATCTGAGGAC and 5'TAGTGTGGAACATTCCTCAC, annealing temperature 55 ºC for 35 cycles; followed
by a nested reaction 5'-CTGACATCTGAGGACTCTGC and 5'GCTGTCACAGAGGTGGTCCTG, annealing temperature 58 ºC for 35 cycles);
VH186.2 (5'- TCTTTACAGTTACTGAGCACACAGGAC and 5'GGGTCTAGAGGTGTCCCTAGTCCTTCATGACC, annealing temperature 50 ºC for
35 cycles; followed by a nested reaction 5'-CAGTAGCAGGCTTGAGGTCTGGAC and
5'- GGGTCTAGAGGTGTCCCTAGTCCTTCATGACC, annealing temperature 64 ºC
for 35 cycles); bcl-6 (5'-GGCCGGACACCAGGTGATTAT and 5'AGGGAGGGAACTACCGCTGAG, annealing temperature 68 ºC for 35 cycles).
PCR products were blunt-end cloned into pSC-B (Stratagene), and sequenced using a
standard T3 primer.

Strand-Specific RT-PCR.
Total RNA was prepared from splenic B cells using Trizol (Invitrogen) and treated with
DNAse I (Promega). The One-Step RT-PCR kit (Qiagen) was used to assay for strand
specific transcripts, where only one primer was added to the reverse transcription
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reaction, followed by addition of the second primer for the PCR amplification rounds.
The primers used were: µ1F – 5’-GCATTTACAGTGACTTTGTTCATG, µ1R – 5’CAGCAGCCTGGTCTCAGAC, µ4F – 5’-GGAACAAGGTTGAGAGCCC, µ4R – 5’CAGCTCACCCCAACACAGC, µ6F – 5’-GGCTGGGTGAGCTGGAG, µ6R – 5’GCTCAGCCCCGTTCATTC, µ8F – 5’-CAGTCCTTCCCAAATGTCTTC, µ8R – 5’GGTATTCATCTGAACCTTCAAG; γ1F – 5’-CTGCTTTCACAGCTTCCACATG, γ1R
– 5’-CCATGCCAAACACATTCCTCAG, γ4F – 5’-CCACTCTTCCATTTGTCCTTG,
γ4R – 5’-GGAGACCAGGCTGAGCAG, γ5F – 5’-CTGCGTCTATTCAGCCTTGAC,
γ5R – 5’-GCCTTGGGAGCCAGAACAG, γ8F – 5’-CCAAACTAACTCCATGGTGAC,
γ8R – 5’-GTCCACCTTGGTGCTGCTG.

5’ RACE PCR.
5’-end mapping of antisense transcripts was carried out using a 5’RACE PCR kit
(Invitrogen), using primers listed above, and the following additional primers: µ1Fn –
5’-GCCTTACTATTAAGACTTTGACATT, µ4Fn – 5’GCGAGGCTCTAAAAAGCAT, µ6Fn – 5’-GAGCTGAGCTGAGGTGAAC, µ8Fn –
5’-CCCCTGTCTGATAAGAATCTG; γ2Fn – 5’-CCTGAGCCCCGAGGATATC, γ5Fn
– 5’-CCAAGGGATAGACATGTAAGC, γ8Fn – 5’-CCTGGGATGCCTGGTCAAG.
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